Skip to main content
Canadian Journal of Public Health = Revue Canadienne de Santé Publique logoLink to Canadian Journal of Public Health = Revue Canadienne de Santé Publique
. 2005 Mar 1;96(2):136–139. doi: 10.1007/BF03403677

Family Physician Visits and Early Recognition of Melanoma

Melanie L Di Quinzio 112, Ron A Dewar 212, Frederick I Burge 312, Paul J Veugelers 112,412,
PMCID: PMC6976111  PMID: 15850035

Abstract

Background

Malignant melanoma is a deadly skin cancer with a rapidly-increasing incidence, mortality and public health burden. Thin melanomas are easily treated with good prognosis, while the thicker lesions have relatively poor survival. To broaden strategies for early recognition of melanoma, we investigated the relationship between primary care service and melanoma thickness at diagnosis.

Methods

All 714 patients diagnosed with a primary malignant melanoma between January 1995 and December 1999 in Nova Scotia were included in the present study and linked to provincial physician billing databases to reveal the patients’ use of family physician services prior to the diagnosis of melanoma. We examined the importance of physician use of services for tumour thickness using logistic regression while adjusting for potential confounders. Tumour thickness was dichotomized to thin and thick using 0.75 mm as a cutoff.

Results

Patients who regularly visited their family physician (2 to 5 times during a two-year interval prior to diagnosis) were 66% (95% CI, 31–84) less likely to be diagnosed with thick melanoma as compared to patients who consulted their family physician less or not at all. Progression to thick tumours could have been reduced by 11.70% (95% CI, -1.33–25.77) if all patients had consulted their family physician at least once a year.

Discussion

Increased awareness of the need for regular medical check-ups could reduce the public health burden of melanoma.

MeSH terms: Melanoma, neoplasms, prevention and control, primary health care, public health

Footnotes

Acknowledgements: This project was funded by the Nova Scotia Health Research Foundation, the Canada Foundation of Innovation and through a Canadian Institutes for Health Research New Investigator Award to Paul J. Veugelers. Although some of the data analyzed were provided by the Nova Scotia Department of Health to the Population Health Research Unit, Dalhousie University, the conclusions are solely those of the authors.

References

  • 1.Weinstock M. Early detection of melanoma. JAMA. 2000;284(7):886–89. doi: 10.1001/jama.284.7.886. [DOI] [PubMed] [Google Scholar]
  • 2.Johnson T, Dolan O, Hamilton T, Lu M, Swanson N, Lowe L. Clinical and histologic trends of melanoma. J A Acad Dermatol. 1998;38(5):681–86. doi: 10.1016/S0190-9622(98)70196-3. [DOI] [PubMed] [Google Scholar]
  • 3.Rigel D, Friedman R, Kopf A. The incidence of malignant melanoma in the United States: Issues as we approach the 21st century. J Am Acad Dermatol. 1996;34(5):839–47. doi: 10.1016/S0190-9622(96)90041-9. [DOI] [PubMed] [Google Scholar]
  • 4.Jerant A, Johnson J, Sheridan C, Caffrey T. Early detection and treatment of skin cancer. Am Fam Phys. 2000;62(2):357–68. [PubMed] [Google Scholar]
  • 5.Surg Clin N Am. 2003.
  • 6.American Cancer Society. Cancer Facts & Figures 2003. 2003. p. 4. [Google Scholar]
  • 7.National Cancer Institute of Canada. Canadian Cancer Statistics 2003. 2003. [Google Scholar]
  • 8.MacKie R. Risk factors for the development of primary cutaneous malignant melanoma. Derm Clin. 2002;20(4):597–600. doi: 10.1016/S0733-8635(02)00028-1. [DOI] [PubMed] [Google Scholar]
  • 9.Armstrong B, English D. Cutaneous malignant melanoma. In: Schottenfeld D, Fraumeni J, editors. Cancer Epidemiology and Prevention. 2nd. New York: Oxford University Press; 1996. pp. 1282–312. [Google Scholar]
  • 10.Elwood J, Gallagher R, Hill G, Spinelli J, Pearson J, Threlfall W. Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. BMJ. 1984;288:99–102. doi: 10.1136/bmj.288.6411.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Goldstein B, Goldstein A. Diagnosis and management of malignant melanoma. Am Fam Phys. 2001;63(7):1359–68. [PubMed] [Google Scholar]
  • 12.DiFronzo L, Wanek L, Morton D. Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routing postoperative follow-up. Cancer. 2001;91:1520–24. doi: 10.1002/1097-0142(20010415)91:8<1520::AID-CNCR1160>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  • 13.Hall H, Miller D, Rogers J, Brewerse B. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol. 1999;40(1):35–42. doi: 10.1016/S0190-9622(99)70562-1. [DOI] [PubMed] [Google Scholar]
  • 14.Roetzheim R, Pal N V, Durme D, Wathington D, Ferrante J, Gonzalez E, et al. Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. J Am Acad Dermatol. 2000;43(2):211–18. doi: 10.1067/mjd.2000.106242. [DOI] [PubMed] [Google Scholar]
  • 15.The Canadian Task Force on the Periodic Health Examinations. The Canadian Guide to Clinical Preventive Health Care. Ottawa: Minister of Supply and Services Canada; 1994. [Google Scholar]
  • 16.Geller A. Screening for melanoma. Derm Clin. 2002;20(4):629–40. doi: 10.1016/S0733-8635(02)00034-7. [DOI] [PubMed] [Google Scholar]
  • 17.Epstein D, Lange J, Gruber S, Mofid M, Koch S. Is physician detection associated with thinner melanomas? JAMA. 1999;281:640–43. doi: 10.1001/jama.281.7.640. [DOI] [PubMed] [Google Scholar]
  • 18.Van Durme D, Ferrante J, Pal N, Wathington D, Roetzheim R, Gonzalez E. Demographic predictors of melanoma stage at diagnosis. Arch Fam Med. 2000;9:606–11. doi: 10.1001/archfami.9.7.606. [DOI] [PubMed] [Google Scholar]
  • 19.Weiss L, Blustein J. Faithful patients: The effect of long-term physician-patient relationships on the costs and use of health care by older Americans. Am J Public Health. 1996;86(12):1742–47. doi: 10.2105/AJPH.86.12.1742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ettner S. The relationship between continuity of care and the health behaviors of patients. Does having a usual physician make a difference? Med Care. 1999;37(6):547–55. doi: 10.1097/00005650-199906000-00004. [DOI] [PubMed] [Google Scholar]
  • 21.Krige J, Isaacs S, Hudson A, King H, Strover R, Johnson C. Delay in the diagnosis of cutaneous malignant melanoma. Cancer. 1991;68:2064–68. doi: 10.1002/1097-0142(19911101)68:9<2064::AID-CNCR2820680937>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  • 22.Brady M, Oliveria S, Christos P, Berwick M, Coit D, Katz J, et al. Patterns of detection in patients with cutaneous melanoma. Cancer. 2000;89:342–47. doi: 10.1002/1097-0142(20000715)89:2<342::AID-CNCR19>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  • 23.Richard M, Grob J, Avril M, Delanunay M, Gouvernet J, Wolkenstein P, et al. Delays in diagnosis and melanoma prognosis (II): The role of doctors. Int J Cancer. 2000;89:280–85. doi: 10.1002/1097-0215(20000520)89:3<280::AID-IJC11>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  • 24.Temoshok L, Diclemente R, Sweet D, Blois M, Sagebiel R. Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma. Cancer. 1984;54:3048–53. doi: 10.1002/1097-0142(19841215)54:12<3048::AID-CNCR2820541239>3.0.CO;2-M. [DOI] [PubMed] [Google Scholar]
  • 25.Veugelers PJ, Yip AM, Kephart G. Proximal and contextual socioeconomic determinants of mortality: Multilevel approaches in a setting with universal health care coverage. Am J Epidemiol. 2001;154:725–32. doi: 10.1093/aje/154.8.725. [DOI] [PubMed] [Google Scholar]
  • 26.Argenziano G, Fabbrocini G, Carli P D, Giorgi V, Delfino M. Epiluminescence microscopy: Criteria of cutaneous melanoma progression. J Am Acad Dermatol. 1997;37(1):68–74. doi: 10.1016/S0190-9622(97)70213-5. [DOI] [PubMed] [Google Scholar]
  • 27.Slingluff C, Jr., Vollmer R, Reintgen D, Seigler H. Lethal “thin” malignant melanoma. Ann Surg. 1988;208(2):150–61. doi: 10.1097/00000658-198808000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Fitzgerald A, Dewar R, Veugelers P. Diet quality and cancer incidence in Nova Scotia, Canada. Nutrition and Cancer. 2002;43(2):127–32. doi: 10.1207/S15327914NC432_2. [DOI] [PubMed] [Google Scholar]
  • 29.Veugelers PJ, Yip AM, Elliott D. Geographic variation in health services use in Nova Scotia. Chron Dis Can. 2003;23:100–10. [PubMed] [Google Scholar]
  • 30.Tsao H, Rogers GS, Sober AJ. An estimate of the annual direct cost of treating cutaneous melanoma. J Am Acad Dermatol. 1998;38:669–80. doi: 10.1016/S0190-9622(98)70195-1. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Journal of Public Health = Revue Canadienne de Santé Publique are provided here courtesy of Springer

RESOURCES